Xu et al used the ratio of serum C-reactive protein (CRP) to albumin to predict prognosis for a patient with operable squamous cell carcinoma of the esophagus. This can help to identify a patient who may benefit from more aggressive management. The authors are from Zhejiang Cancer Hospital, Hanggan Hospital, and the Second of Yuhang People’s Hospital in China.